Prevention of Cyclophosphamide-Induced Immunosuppression in Mice with the Antimicrobial Peptide Sublancin

Figure 4

Effects of sublancin on numbers of red blood cells (RBC, 10¹²/L) (a), hemoglobin (HGB, g/L) (b), white blood cells (WBC, 10⁹/L) (c), and platelet (10¹¹/L) (d) in cyclophosphamide-treated mice. NC (normal control) = mice were treated with saline; MC (model control) = mice were administered with cyclophosphamide 80 mg/kg/d via i.p. injection for 3 days and gavaged with saline for 7 days; sublancin (2.0, 4.0, and 8.0) = mice were administered with cyclophosphamide 80 mg/kg/d via i.p. injection for 3 days and gavaged with sublancin at 2.0, 4.0, or 8.0 mg/kg/d for 7 days, respectively; LH (10.0) = mice were administered with cyclophosphamide 80 mg/kg/d via i.p. injection for 3 days and gavaged with levamisole hydrochloride for 7 days. Values are expressed as means ± SEM (); , , and compared with NC group. , , and compared with MC group.

(a)

(b)

(c)

(d)